COX CARRIE SMITH 4
4 · Solventum Corp · Filed May 18, 2026
Research Summary
AI-generated summary of this filing
Solventum (SOLV) Director Carrie Smith Cox Receives 4,848 RSUs
What Happened
Carrie Smith Cox, a director of Solventum Corp (SOLV), received a grant of 4,848 restricted stock units (RSUs) on May 15, 2026. The award is reported at $0.00 per unit (derivative grant); the RSUs represent contingent rights to receive one share each upon settlement. This was an equity award (not an open-market buy or sale) and does not represent an immediate purchase or sale of common stock.
Key Details
- Transaction date: 2026-05-15
- Filing date: 2026-05-18 (filed within the Form 4 two-business-day window)
- Transaction code: A (award/grant) — derivative instrument (RSUs)
- Amount: 4,848 RSUs reported at $0.00 per unit
- Shares owned after transaction: Not disclosed in the provided filing
- Footnotes: F1 — each RSU equals a contingent right to 1 share; F2 — RSUs fully vest on May 15, 2027 subject to continued service
Context
RSU grants are commonly used for compensation and retention; they convert into actual shares only upon vesting and settlement, so they do not immediately change the insider’s beneficial ownership or reflect a market bet. For retail investors, purchases and sales typically signal more immediate sentiment than awards; this filing documents a future potential increase in outstanding shares if and when the RSUs vest and are settled.
Insider Transaction Report
- Award
Restricted Stock Units
[F1][F2]2026-05-15+4,848→ 4,848 total→ Common Stock (4,848 underlying)
Footnotes (2)
- [F1]Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.
- [F2]The RSUs shall fully vest on May 15, 2027, subject to continued service through the vesting date.